EN editorial director Martin Fullard welcomes news of a vaccine, but says rapid testing will speed up the return. It is uncanny: the very moment I sat down to write this article a BBC News notification popped up on my phone saying that US pharmaceutical firm Moderna has developed a vaccine, which early data shows is 95% effective against COVID-19. This news comes less than a week after Pfizer went public with news that its vaccine is 90% effective. ...